Release Date: 22/02/13 09:38 Summary: Mailout to shareholders - Investment Opportunity Price Sensitive: No Download Document 1.44MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago